Competing performance measures in predicting shareholder return of Indian pharmaceutical firms: an empirical evidence Online publication date: Thu, 09-May-2019
by Merugu Venugopal; M. Ravindar Reddy; Bhanu Prakash Sharma G.
International Journal of Business Excellence (IJBEX), Vol. 18, No. 2, 2019
Abstract: The impetus of this paper is to examine the superiority of modern value-based measures over traditional accounting measures in predicting the shareholder return measured as the stock price appreciation and dividend paid during a period. To examine relative and incremental information content, panel data regression models were used on sample data of 77 BSE listed pharmaceutical firms during the period from 2007 to 2015. The relative information content test reveals that the EPS outperformed the modern value-based measure. And also, incremental information content test reveals that the modern value-based measures significantly predict shareholder return than accounting measures. The results suggest that the managers and investors need to consider the value-based measures in assessing the firms' performance. For evaluating the firms' ability in generating higher returns they also need to consider market conditions, capital intensity and other determinants.
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Business Excellence (IJBEX):
Login with your Inderscience username and password:
Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.
If you still need assistance, please email subs@inderscience.com
Our Blog 
Follow us on Twitter 
Visit us on Facebook